Best practice for statisticians in industry sponsored trialsBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d1636 (Published 15 March 2011) Cite this as: BMJ 2011;342:d1636
- Steven A Julious, reader in medical statistics1,
- Stephen Pyke, VP statistics, Pfizer, and chair, Statisticians in the Pharmaceutical Industry (PSI)2,
- Sara Hughes, head of statistics, ViiV Healthcare, and former chair, Statisticians in the Pharmaceutical Industry (PSI)3
- 1Medical Statistics Group, School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, UK
- 2Pfizer, Sandwich, Kent CT13 9NJ, UK
- 3ViiV Healthcare, Brentford, Middlesex TW8 9GS, UK
In light of CONSORT 2010,1 the recently proposed best practice for statisticians in reporting industry sponsored trials should be highlighted.2 The eight recommendations below were explained in two accompanying articles.3 4 A forum for editors, industry, and academia to discuss the issues raised would be beneficial.
(1) The statistical author should be responsible for the statistical aspects of the paper—the authoring …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial